DYCLOPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dyclopro, and what generic alternatives are available?
Dyclopro is a drug marketed by Septodont and is included in one NDA.
The generic ingredient in DYCLOPRO is dyclonine hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dyclonine hydrochloride profile page.
Summary for DYCLOPRO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYCLOPRO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DYCLOPRO
US Patents and Regulatory Information for DYCLOPRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septodont | DYCLOPRO | dyclonine hydrochloride | SOLUTION;TOPICAL | 200480-001 | Nov 20, 2018 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Septodont | DYCLOPRO | dyclonine hydrochloride | SOLUTION;TOPICAL | 200480-002 | Nov 20, 2018 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |